Barclays analyst Lauren Lieberman lowered the firm’s price target on Keurig Dr Pepper (KDP) to $39 from $41 and keeps an Overweight rating on the shares. The firm says there was a lot to unpack from the company’s earnings update. While there are lingering questions still to be answered, Barclays believes Keurig remains anchored to 7% earnings growth in 2025, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Keurig Dr Pepper price target raised to $42 from $41 at RBC Capital
- Keurig Dr Pepper price target lowered to $41 from $42 at Jefferies
- Keurig Dr Pepper price target lowered to $40 from $43 at Citi
- Keurig Dr Pepper Expands with GHOST Lifestyle Acquisition
- Morning Movers: UPS ascends and Textron descends after quarterly reports